JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article


FIGURE 4. Cross section of CAP stained with antihuman nuclear Ki-67 antibody MIB-1 and lightly counterstained with hematoxylin. Amount of Ki-67–positive tumor cells is approximately 2% in this cross section. Left upper part of figure shows newly formed reactive lymph node with lightly positive Ki-67 immunostaining. (x200)





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE